Logo
Daily Brief
Following Why
The Quiet War on Blindness

The Quiet War on Blindness

How the world is dismantling trachoma, humanity's oldest eye disease

Overview

For the first time since records began, fewer than 100 million people need treatment for trachoma—a bacterial eye disease that's been blinding humans since ancient Egyptian times. The number at risk has cratered 94% since 2002, from 1.5 billion to 97 million. Twenty-seven countries have eliminated it entirely.

This isn't a vaccine miracle or a pharmaceutical breakthrough. It's soap, antibiotics, and eyelid surgery delivered to the world's poorest villages. The question now: Can the final 97 million be reached by 2030, or will funding gaps and conflict zones turn this into another almost-won war?

Key Indicators

94%
Reduction in people at risk since 2002
From 1.5 billion to 97.1 million requiring interventions
27
Countries that eliminated trachoma
Validated by WHO as free of trachoma as a public health problem
$300M
Funding gap to reach 2030 target
Needed for surgery, antibiotics, surveys, and research
1B
Antibiotic doses donated
Pfizer's Zithromax donations through 2023

People Involved

Tedros Adhanom Ghebreyesus
Tedros Adhanom Ghebreyesus
WHO Director-General (Leading global health coordination)
Dr. Anthony Solomon
Dr. Anthony Solomon
WHO Medical Officer for Trachoma (Leading WHO's global trachoma elimination programme)

Organizations Involved

WO
World Health Organization
UN Agency
Status: Coordinating global elimination campaign

Global health authority setting trachoma elimination targets and validating country achievements.

IN
International Trachoma Initiative
Global Health Partnership
Status: Coordinating antibiotic donations and technical support

Partnership managing Pfizer's billion-dose antibiotic donation program for trachoma elimination.

Pfizer Inc.
Pfizer Inc.
Pharmaceutical Company
Status: Donating antibiotics through 2030

Co-founded trachoma initiative and committed to donate Zithromax antibiotics through 2030.

Timeline

  1. Global Trachoma Cases Fall Below 100 Million

    Milestone

    WHO announces 97.1 million people requiring interventions, first time below 100 million. Marks 94% reduction since 2002.

  2. Egypt Validated as Trachoma-Free

    Elimination

    Egypt becomes seventh Eastern Mediterranean country to eliminate trachoma, 27th globally.

  3. Fiji Becomes 26th Country

    Elimination

    Fiji validated for eliminating trachoma as public health problem.

  4. Senegal Validated

    Elimination

    Senegal joins growing list of countries eliminating trachoma.

  5. Burundi Eliminates Trachoma

    Elimination

    Burundi validated by WHO as having eliminated trachoma as public health problem.

  6. Papua New Guinea and Mauritania Validated

    Elimination

    WHO validates both countries for eliminating trachoma as public health problem.

  7. WHO Declares 'Golden Age of Elimination'

    Statement

    Dr. Tedros recognizes 11 countries for eliminating NTDs since January 2024 at World Health Assembly.

  8. One Billion Doses Delivered

    Milestone

    ITI and Pfizer announce one billionth Zithromax dose donated for trachoma treatment.

  9. Pfizer Extends Commitment

    Funding

    Pfizer commits to continue donating azithromycin through 2030, supporting final elimination push.

  10. Original Elimination Target Missed

    Assessment

    WHO extends global elimination deadline from 2020 to 2030 after falling short. Nine countries validated by then.

  11. 137 Million Still at Risk

    Data

    Number requiring interventions falls to 137 million, a 91% reduction from 2002 baseline.

  12. Mapping Project Completed

    Research

    GTMP finishes examining 2.6 million people, providing unprecedented data for targeting interventions.

  13. Global Trachoma Mapping Project Begins

    Research

    Largest infectious disease survey launches, using smartphones to map trachoma in 29 countries.

  14. First Eliminations Validated

    Milestone

    Oman becomes first country validated by WHO for eliminating trachoma as public health problem.

  15. Baseline Established

    Data

    WHO estimates 1.5 billion people at risk of trachoma, 7.6 million needing trichiasis surgery.

  16. Trachoma Elimination Campaign Launches

    Initiative

    Pfizer and Edna McConnell Clark Foundation establish International Trachoma Initiative. WHO endorses SAFE strategy globally.

Scenarios

1

Global Elimination Achieved by 2030

Discussed by: WHO, International Trachoma Initiative, public health analysts

The remaining 32 endemic countries receive adequate funding ($300M identified gap), maintain political commitment, and successfully implement SAFE strategy in final hard-to-reach communities. Surgery backlog cleared through trained non-physician providers. Mass antibiotic distribution reaches remote villages. Facial cleanliness and water access programs sustained. All countries validated by 2030 deadline, making trachoma the second disease ever eradicated as a public health problem globally after smallpox.

2

Partial Success: Most Countries Eliminate, Pockets Remain

Discussed by: Lancet Global Health analysis, LSHTM researchers

Majority of endemic countries achieve elimination, but conflict zones (parts of Ethiopia, Sudan, Chad, South Sudan) and extremely remote areas prove unreachable. Funding gaps slow surgery programs. By 2030-2035, trachoma eliminated in 40+ countries but persists in isolated pockets with perhaps 10-20 million still at risk. Becomes similar to Guinea worm: nearly eradicated but lingering in fragile states. Recrudescence in some Ethiopian districts shows disease can return after apparent control.

3

Stalled Progress and Resurgence

Discussed by: Public health contingency planning, funding agencies

Funding gap remains unfilled as donor fatigue sets in. COVID-19 and future pandemics repeatedly disrupt mass drug administration campaigns. Climate change worsens water scarcity in endemic regions, undermining environmental improvement efforts. Political instability in African endemic countries halts programs. Surgery backlog grows faster than capacity. By 2035, progress reverses in some areas with cases climbing back above 100 million. Elimination postponed to 2040s or abandoned as countries deprioritize.

Historical Context

Smallpox Eradication (1967-1980)

1967-1980

What Happened

WHO launched intensive global campaign using ring vaccination strategy, tracking every outbreak, and vaccinating contacts. Disease declared eradicated in 1980—the only human infectious disease ever completely eliminated. Last natural case occurred in Somalia in 1977.

Outcome

Short Term

WHO declared world free of smallpox on May 8, 1980.

Long Term

Saves over $1 billion annually since 1980; proved disease eradication feasible with sustained commitment.

Why It's Relevant Today

Trachoma could become second disease eliminated globally as public health problem, but unlike smallpox requires behavior change (facial cleanliness, water access) not just medical intervention, making complete eradication more complex.

Guinea Worm Eradication Campaign (1986-present)

1986-present

What Happened

Carter Center led campaign reduced Guinea worm cases from 3.5 million annually in 20 countries to fewer than 15 cases by 2021. Used community-based surveillance and behavior change—no vaccine or cure exists. Achieved 99.99% reduction through education and clean water access.

Outcome

Short Term

Seventeen countries certified Guinea worm-free by 2022, including Ghana and DRC.

Long Term

Final eradication delayed repeatedly by conflict in South Sudan, Chad; demonstrates how political instability can stall final elimination stages.

Why It's Relevant Today

Shows behavior-change-based elimination can succeed but takes decades. Also warns that final mile—reaching last pockets in conflict zones—can drag on indefinitely despite 99%+ reduction.

Polio Eradication Effort (1988-present)

1988-present

What Happened

Global campaign reduced wild polio by 99.9% from 350,000 annual cases in 125 countries to fewer than 50 cases in two endemic countries (Pakistan and Afghanistan) by 2020s. Uses mass vaccination campaigns, but faces vaccine hesitancy and access issues in conflict zones.

Outcome

Short Term

Certified eradication in multiple regions; Africa declared wild polio-free in 2020.

Long Term

Final elimination repeatedly delayed; vaccine-derived polio emerged as new challenge requiring continued vigilance.

Why It's Relevant Today

Demonstrates that even with 99%+ reduction, final eradication can remain elusive for decades when disease persists in fragile states. Trachoma faces similar challenges in Ethiopia, Chad, South Sudan.

11 Sources:
+6
World Health Organization The Lancet Global Health Pfizer Inc. Sightsavers Uniting to Combat NTDs World Health Organization World Health Organization World Health Organization World Health Organization World Health Organization The Lancet